19. Lysosomal storage disease Clinical trials / Disease details
Clinical trials : 854 / Drugs : 716 - (DrugBank : 105) / Drug target genes : 70 - Drug target pathways : 191
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01165697 (ClinicalTrials.gov) | July 2010 | 16/7/2010 | Establishment of Biomarkers for Fabry Disease | Establishment of Biomarkers for Fabry Disease | Fabry Disease | Other: Fluorescein angiography | Ohio State University | Genzyme, a Sanofi Company | Completed | 18 Years | N/A | All | 4 | N/A | United States |